Literature DB >> 1882522

[The isolation and characteristics of reassortants between the Lassa and Mopeia arenaviruses].

I S Lukashevich, A D Vasiuchkov, T A Stel'makh, E P Scheslenok, A G Shabanov.   

Abstract

Reassortants with a mixed phenotype were produced by combined inoculation of Vero cells with Lassa and Mopeya viruses. These reassortants produced small plaques (Mopeya virus phenotype) and were not pathogenic for newborn mice (Lassa virus phenotype). The genotype of the reassortants was studied by dot hybridization experiments on filters using cDNA-probes differentiating genome segments of these viruses. The reassortants were shown to have Mopeya virus L-RNA and Lassa virus S-RNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882522

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  10 in total

1.  Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.

Authors:  Dmitry A Moshkoff; Maria S Salvato; Igor S Lukashevich
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

2.  A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

Authors:  Igor S Lukashevich; Jean Patterson; Ricardo Carrion; Dmitry Moshkoff; Anysha Ticer; Juan Zapata; Kathleen Brasky; Robert Geiger; Gene B Hubbard; Joseph Bryant; Maria S Salvato
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

4.  Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.

Authors:  Lei-Ke Zhang; Qi-Lin Xin; Sheng-Lin Zhu; Wei-Wei Wan; Wei Wang; Gengfu Xiao
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

5.  A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of Machupo virus.

Authors:  Michael Patterson; Takaaki Koma; Alexey Seregin; Cheng Huang; Milagros Miller; Jennifer Smith; Nadezhda Yun; Jeanon Smith; Slobodan Paessler
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

6.  Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.

Authors:  Igor S Lukashevich; Ilia Tikhonov; Juan D Rodas; Juan C Zapata; Yida Yang; Mahmoud Djavani; Maria S Salvato
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.

Authors:  Nikole L Warner; Jenny D Jokinen; Juliane I Beier; Kevin J Sokoloski; Igor S Lukashevich
Journal:  Viruses       Date:  2018-02-10       Impact factor: 5.048

Review 8.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

Review 9.  Current research for a vaccine against Lassa hemorrhagic fever virus.

Authors:  Bryce M Warner; David Safronetz; Derek R Stein
Journal:  Drug Des Devel Ther       Date:  2018-08-14       Impact factor: 4.162

Review 10.  Arenavirus genetic diversity and its biological implications.

Authors:  Sebastien F Emonet; Juan C de la Torre; Esteban Domingo; Noemí Sevilla
Journal:  Infect Genet Evol       Date:  2009-03-25       Impact factor: 3.342

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.